Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating?

Area of Science:

• Gerontology
• Clinical Nutrition
• Biomedical Engineering

Background:

• Bioelectrical impedance analysis (BIA) is widely adopted for sarcopenia and cachexia assessment due to the lack of reference methods for low skeletal muscle mass.
• BIA allows for the evaluation of various 'muscularity' components using different equations, commonly reporting skeletal muscle mass index or appendicular skeletal muscle index.
• Consensus guidelines utilize these indices for sarcopenia definition, though the terms 'skeletal muscle mass' and 'appendicular skeletal muscle mass' are not interchangeable.

Discussion:

• Discrepancies exist in sarcopenia definitions derived from BIA across different consensus groups, potentially leading to overestimation of sarcopenia and cachexia.
• The current lack of standardized terminology for low muscularity and sarcopenia assessed by BIA hinders consistent clinical application.
• The use of BIA for sarcopenia assessment requires careful selection of appropriate equations and population-specific cut-off values.

Key Insights:

• Bioelectrical impedance analysis (BIA) is a practical tool for assessing low skeletal muscle mass in clinical settings.
• Standardization of BIA methodologies and terminology is crucial to avoid overdiagnosis of sarcopenia and cachexia.
• Population-specific validation studies are necessary to establish accurate BIA-derived cut-off values.

Outlook:

• Future research should focus on standardizing BIA equations and terminology for sarcopenia assessment.
• Development of universally accepted BIA protocols will enhance diagnostic accuracy and clinical utility.
• Further validation studies are required to refine BIA-based sarcopenia definitions across diverse populations.